CALC CalciMedica, Inc.
Company Analysis
Latest News
🔴 CalciMedica is trading 5.5% down with no clear company-specific catalyst
CalciMedica is trading 5.5% lower at $1.20, with no clear company-specific announcement explaining the decline. - Broad market indexes were mixed, rather than...
🟢 CalciMedica is trading 6.1% up in after-hours trading
CalciMedica is trading 6.11% higher at $1.39 in after-hours on October 8, with no company-specific announcement identified. - CalciMedica closed the regular...
🔴 CalciMedica is trading 10.67% down amid biotech and broader market weakness
CalciMedica is trading 10.67% down at $1.34, amid broader biotech and market weakness, with no verified company-specific announcement identified for October...
🔴 CalciMedica is trading 5.3% down today amid biotech-sector weakness
CalciMedica is trading 5.33% lower at $1.42, with broader biotech weakness the clearest contemporaneous context. - Biotech ETF XBI is down 2.04% during the...
🔴 CalciMedica is trading 6.5% down today with no clear company-specific catalyst
CalciMedica is trading 6.5% down at $1.44 on October 6, 2026, with no new company-specific announcement clearly explaining the decline. - A September 30...
🟢 CalciMedica is trading 5.56% up in pre-market; no clear catalyst identified
CalciMedica is trading 5.56% up in pre-market at $1.71 on October 5, with no clear company-specific catalyst identified. - The October 2 close was $1.60. - A...
🔴 CalciMedica is trading 6.17% down in pre-market with no clear company-specific catalyst identified
CalciMedica is trading at $1.52, down 6.17%, in pre-market, with no clear company-specific catalyst identified for the October 5 decline. • The latest SEC...
🟢 CalciMedica is trading 10.4% up in pre-market with no clear catalyst identified
CalciMedica is trading 10.37% higher at $1.81 in pre-market on October 2, 2026; the cause remains uncertain. - Shares closed at $1.65 on October 1. - A...
🟢 CalciMedica is trading 9.8% up in after-hours trading with no clear catalyst identified
CalciMedica is trading at $1.80, up 9.76%, in after-hours trading with no verified October 1 announcement or clear catalyst identified. - A September 30...
🟢 CalciMedica is trading 5.43% up
CalciMedica is trading at $1.71, up 5.43%; no clear company-specific catalyst for the gain was found. - A September 30 prospectus supplement disclosed up to...
🔴 CalciMedica is trading 6.17% down in pre-market amid potential $25 million stock-sale filing
CalciMedica is trading 6.17% down at $1.52 in pre-market on October 1, amid a September 30 filing allowing up to $25 million in common-stock sales; whether it...
CalciMedica Files to Sell Up to $25M in Stock via At-The-Market Offering
CalciMedica has filed a prospectus supplement related to the potential sale of its common stock, with an aggregate offering price of up to $25 million, through...
🔴 CalciMedica is trading 5.6% down
CalciMedica is trading 5.6% lower at $1.60; no clear company-specific catalyst for the September 29 move was identified. - The decline follows a 4.0% loss at...
🔴 CalciMedica is trading 5.7% down today with no identified company-specific catalyst
CalciMedica is trading 5.7% lower at $1.65, with no clear company-specific catalyst identified for the September 28 decline. - The company’s...
🔴 CalciMedica is trading 6.32% down today with no clear catalyst identified
CalciMedica is trading 6.32% lower at $1.63, down from its September 24 close of $1.74; no company-specific catalyst for the September 25 decline was...
🟢 CalciMedica is trading 6.67% up in after-hours trading
CalciMedica is trading at $1.92, up 6.67%, after hours; no confirmed company-specific catalyst for the move was identified. - It closed at $1.80 on September...
🔴 CalciMedica is trading 5.35% down today as risk-off pressure weighs on biotech stocks
CalciMedica is trading 5.35% down at $1.77 as broader risk-off pressure hits biotechnology and growth stocks. - The biotech XBI sector is down 2.04%, while...
🟢 CalciMedica is trading 7.49% up in pre-market amid stronger biotech-sector sentiment
CalciMedica is trading 7.49% higher at $2.01 in pre-market amid stronger biotech-sector sentiment, with no definitive company-specific catalyst identified for...
🟢 CalciMedica is trading 6.4% up today with no definitive catalyst identified
CalciMedica is trading 6.4% up at $1.98, although available evidence does not establish a definitive catalyst. - No clear company-specific announcement dated...
CalciMedica Regains Compliance with Nasdaq Minimum Bid Price Requirement
CalciMedica, Inc. (CALC) announced it has regained compliance with The Nasdaq Stock Market's minimum bid price requirement, resolving a previous deficiency...